Busy. Please wait.

Forgot Password?

Don't have an account?  Sign up 

show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.

By signing up, I agree to StudyStack's Terms of Service and Privacy Policy.

Already a StudyStack user? Log In

Reset Password
Enter the email address associated with your account, and we'll email you a link to reset your password.

Remove ads
Don't know (0)
Know (0)
remaining cards (0)
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
restart all cards

Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how


multiple endocrine neoplasia

MEN stands for: multiple endocrine neoplasia
MEN is: disorders of endocrine excess; group of hereditary syndromes characterized by aberrant growth of malignant and benign tumors in multiple endocrine glands
MEN syndromes include: Wermer syndrome (MEN-1); Sipple syndrome (MEN-2a); Mucosal neuroma syndrome (MEN-2b)
Wermer syndrome (MEN-1) 3 P's: pituitary, parathyroid, pancreas (also facial angiofibromas)
Sipple syndrome (MEN-2a): medullary thyroid carcinoma, parathyroid, pheochromocytoma
Mucosal neuroma syndrome (MEN-2b): medullary thyroid carcinoma, pheochromocytoma, mucosal and GI ganglioneuromas, (parathyroid tumor is rare)
Which is more common: MEN-1 or MEN-2? MEN-1
Which is more common: MEN-2a or MEN-2b? MEN-2a
Which of the 3 MEN forms is more aggressive with a worse prognosis? MEN-2b
MEN-1 treatment hypercalcemia (surgery); gastrinoma (PPIs); insulinoma (surgery, diazoxide); glucagonoma (surgery); prolactinoma (dopamine agonist); GH (trans-sphenoidal surgery)
Most common clinical manifestation of MEN-2: medullary thyroid carcinoma
Second most common clinical manifestation of MEN-2: pheochromocytoma
Common in MEN-2a but not in MEN-2b: parathyroid tumors
MEN-2 treatment total thyroidectomy with radical lymph node dissection (for medullary thyroid carcinoma); surgical excision under alpha-adrenergic blockade (for pheochromocytoma)
Created by: Carrie D.